Clinical Trial Update: Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial to assess the safety and tolerability of RPESC-RPE transplantation in patients with dry age-related macular degeneration; recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Dry Age-related Macular Degeneration

Drugs mentioned

• RPESC-RPE (RPESC-RPE)

Snippet

Sponsor: Luxa Biotechnology, LLC | Conditions: Dry Age-related Macular Degeneration | Phase 1, Phase 2 | Status: RECRUITING